Gynostemma pentaphyllum saponins attenuate inflammation in vitro and in vivo by inhibition of NF-κB and STAT3 signaling

Recent advances in the development of anti-inflammatory agents have improved their therapeutic outcome in inflammatory bowel disease (IBD), however, the presence of side effects and limited effectiveness hinder their widespread use. Therefore, novel compounds with strong anti-inflammatory efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Wing-Yan, Lee, Magnolia Muk-Lan, Chan, Brandon Dow, Ma, Victor Wan-San, Zhang, Wenchun, Yip, Timothy Tak-Chun, Wong, Wing-Tak, Tai, William Chi-Shing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675642/
https://www.ncbi.nlm.nih.gov/pubmed/29152090
http://dx.doi.org/10.18632/oncotarget.20997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675642/
https://www.ncbi.nlm.nih.gov/pubmed/29152090
http://dx.doi.org/10.18632/oncotarget.20997

Ejemplares similares